Real-Time Molecular Sensing Heralds New Era Of Continuous Monitoring
The Case For DNA Aptamer-Based Sensors In Monitoring Vancomycin Concentrations And Creatinine Levels In Real-Time
Executive Summary
The traditional method of performing conventional lab diagnostic testing, using blood draws and waiting often long periods for the results, presents challenges for clinicians dealing with complex medical conditions. Continuous diagnostic monitoring based on real-time molecular sensing is the long-awaited solution.
You may also be interested in...
US FDA’s START Program Might See Expanded Funding If Pilot Meets Speed Goals
The program bringing Operation Warp Speed-like treatment to rare disease product development could expand if successful, but will require more employees and thus funding commitments from Congress and industry, CBER Director Peter Marks said.
Did Product Quality Decline While US FDA Inspectors Were Away?
Academics assert more should be done to restore pre-pandemic site-inspection activity levels, especially abroad, following analysis of 10 years of data on US FDA inspection trends, costs and resources published in Health Affairs.
Clinical Trial Diversity Planning Requires Prevalence-Based Enrollment Goals, Metrics For Gauging Success
Academic and industry experts caution against relying on historical enrollment numbers when setting new targets for under-represented populations and tout real-time monitoring dashboards, as well as a role for data monitoring committees, in assessing whether targets are being met in ongoing studies.